Sex-Specific Contribution of Cardiometabolic Index in Predicting Metabolic Dysfunction-Associated Fatty Liver Disease: Insights from a General Population

被引:5
|
作者
Gu, Dongxing [1 ]
Lu, Yayun [1 ]
Xu, Baiqing [1 ,3 ]
Tang, Xuefeng [2 ,3 ]
机构
[1] Huadong Sanat, Hlth Examinat Ctr, Wuxi, Peoples R China
[2] Huadong Sanat, Dept Hlth Nursing, Wuxi, Peoples R China
[3] Huadong Sanat, 67 Jinyuan Rd, Wuxi 214065, Peoples R China
关键词
metabolic dysfunction-associated fatty liver disease; cardiometabolic index; sex; general population; predicting value; LIPOPROTEIN-CHOLESTEROL RATIO; TO-HEIGHT RATIO; HEPATIC STEATOSIS; RISK; OBESITY; TRIGLYCERIDES; ADIPOSITY; LIPIDS; MAFLD;
D O I
10.2147/DMSO.S437413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objective: Evidence suggests that cardiometabolic index (CMI) has been identified as a novel obesity-related index associated with diabetes, hypertension, and cardiovascular disease. Current evidence suggests that the differences in sex hormones and regional fat distribution in both sexes are directly correlated with metabolic dysfunction-associated fatty liver disease (MAFLD) risk. This study aimed to investigate the diagnostic value of CMI in MAFLD in both sexes.Methods: This retrospective study included 6107 subjects who underwent annual health check-ups from March 2021 to January 2022. CMI was calculated by multiplying the ratio of triglycerides and high-density lipoprotein cholesterol (TG/HDL-C) by waist-to-height ratio (WHtR). Multivariable logistic regression analysis and restricted cubic spline were used to investigate the association of CMI and MAFLD risk. Receiver operating characteristic curve analysis was conducted for the exploration of the diagnostic accuracies of obesity-related indicators. Areas under the curves (AUCs) with 95% CIs were calculated.Results: Prevalence of MAFLD increased with elevated quartiles of CMI in both sexes. The median (IQR) age was 46.00 (18.00) years. Multivariate logistic regression analyses showed that higher CMI was independently associated with MAFLD, in which every additional standard deviation (SD) of CMI increased the risk of MAFLD (OR=2.72, 95% CI:2.35-3.15 for males; OR=3.26, 95% CI:2.36-4.51 for females). Subjects in the fourth quartile of CMI had the highest odds of MAFLD for males (OR=15.82, 95% CI:11.84-21.14) and females (OR=22.60, 95% CI:9.52-53.65)(all P for trend<0.001). Besides, CMI had a non-linearity association with MAFLD (all P for non-linearity<0.001). Furthermore, CMI exhibited the largest AUC compared to other obesity-related indexes in terms of discriminating MAFLD in males (AUC=0.796, 95% CI:0.782-0.810) and females (AUC=0.853, 95% CI:0.834-0.872).Conclusion: CMI was a convenient indicator for the screening of MAFLD among Chinese adults. Females with high CMI had a better diagnostic value for MAFLD than males.
引用
收藏
页码:3871 / 3883
页数:13
相关论文
共 50 条
  • [1] Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease
    Perdomo, Carolina M.
    Nunez-Cordoba, Jorge M.
    Ezponda, Ana
    Mendoza, Francisco J.
    Ampuero, Javier
    Bastarrika, Gorka
    Fruhbeck, Gema
    Escalada, Javier
    FRONTIERS IN MEDICINE, 2022, 9
  • [2] Childhood maltreatment and risk of metabolic dysfunction-associated steatotic liver disease - Evidence of sex-specific associations in the general population
    Siewert-Markus, Ulrike
    Ittermann, Till
    Klinger-Koenig, Johanna
    Grabe, Hans J.
    Stracke, Sylvia
    Volzke, Henry
    Targher, Giovanni
    Doerr, Marcus
    Markus, Marcello R. P.
    Toepfer, Philipp
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2024, 183
  • [3] Sex-Specific Associations Between Organophosphate Esters Metabolites and Metabolic Dysfunction-Associated Fatty Liver Disease in Chinese Adults
    Liu, Qing
    Fan, Gaojie
    Bi, Jianing
    Qin, Xiya
    Fang, Qing
    Wu, Mingyang
    Mei, Surong
    Wan, Zhengce
    Lv, Yongman
    Wang, Youjie
    Song, Lulu
    Chen, Hui
    EXPOSURE AND HEALTH, 2024, 16 (06) : 1355 - 1363
  • [4] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    Han, A. Lum
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [5] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    A Lum Han
    Diabetology & Metabolic Syndrome, 14
  • [6] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [7] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [8] Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers
    Liu, Zhenqiu
    Lin, Chunqing
    Suo, Chen
    Zhao, Renjia
    Jin, Li
    Zhang, Tiejun
    Chen, Xingdong
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 127
  • [9] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Alam, Shahinul
    Fahim, Shah Mohammad
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (10) : 1203 - 1207
  • [10] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Shahinul Alam
    Shah Mohammad Fahim
    World Journal of Hepatology, 2021, 13 (10) : 1203 - 1207